Theralase Technologies Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.02 |
Market Cap |
$50.25 M |
Shares Outstanding |
121.28 M |
Public Float |
- |
Theralase Technologies Inc. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.03 |
Market Cap |
CAD65.2 M |
Shares Outstanding |
146.31 M |
Public Float |
128.74 M |
Address |
41 Hollinger Road Toronto Ontario M4B 3G4 Canada |
Employees | - |
Website | http://www.theralase.com |
Updated | 07/08/2019 |
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Photo Dynamic Therapy (PDT) and Therapeutic Laser Technology (TLT) divisions. The Photo Dynamic Therapy segment is involved in the research and development of photo dynamic compounds for the treatment of cancer. |